|
Late deaths
|
|
Cardiac
| | |
|
Not valve related
| | |
|
Cardiac arrest
|
2 (1 in Group II)
|
No
|
|
Valve related
| | |
|
Endocarditis (reoperation)
|
2
|
Yes
|
|
Stroke
| |
1
|
|
Renal
|
1
|
No
|
|
Cancer
|
1
|
Yes
|
|
Unknown
|
1
|
Yes
|
|
Major adverse events
| | |
|
Endocarditis
|
4 (1 in Group II)
|
2 Yes
|
|
Myocardial ischemia
|
2
|
Yes
|
|
Important paravalvular leak
|
2 (1 in Group II)
|
Yes
|
|
Aortic dissection
|
1
|
Yes
|
|
Important mitral valve regurgitation
|
1 (Group II)
|
Yes
|
|
Minor adverse events
|
|
aRenal insufficiency requiring hemodialysis
|
1
|
No
|
|
Reversible ischemic neurologic deficit
|
3
|
No
|
|
Moderate paravalvular leak
|
3
|
No
|
|
Gastric hemorrhage
|
1
|
Yes
|
